“…Another RCT studied intracameral 0.5% moxifloxacin and reported that intracameral moxifloxacin was associated with a reduced rate of endophthalmitis [ 94 ]. In addition, many retrospective series and prospective studies have reported benefits with intracameral antibiotic prophylaxis in cataract surgery [ 88 , 95 , 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 ]. Further, several meta-analyses have also supported the use of intracameral antibiotics, highlighting a greater effectiveness of this route as a prophylactic measure and a lack of additional benefits from topical antibiotic administration [ 100 , 105 , 106 ].…”